Correlation Between Tarsus Pharmaceuticals and MSP Recovery

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and MSP Recovery at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and MSP Recovery into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and MSP Recovery, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and MSP Recovery and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of MSP Recovery. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and MSP Recovery.

Diversification Opportunities for Tarsus Pharmaceuticals and MSP Recovery

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tarsus and MSP is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and MSP Recovery in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MSP Recovery and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with MSP Recovery. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MSP Recovery has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and MSP Recovery go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and MSP Recovery

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.15 times more return on investment than MSP Recovery. However, Tarsus Pharmaceuticals is 6.53 times less risky than MSP Recovery. It trades about 0.34 of its potential returns per unit of risk. MSP Recovery is currently generating about -0.01 per unit of risk. If you would invest  5,066  in Tarsus Pharmaceuticals on October 9, 2024 and sell it today you would earn a total of  554.00  from holding Tarsus Pharmaceuticals or generate 10.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy75.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  MSP Recovery

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
MSP Recovery 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MSP Recovery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, MSP Recovery is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Tarsus Pharmaceuticals and MSP Recovery Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and MSP Recovery

The main advantage of trading using opposite Tarsus Pharmaceuticals and MSP Recovery positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, MSP Recovery can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MSP Recovery will offset losses from the drop in MSP Recovery's long position.
The idea behind Tarsus Pharmaceuticals and MSP Recovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies